根据基线蛋白尿和估计的GFR对IgA脏病的皮质类固醇影响
Dana Kim1,2, Brendon L Neuen1,3, Jicheng Lv4
1The George Institute for Global Health, University of New South Wales, Sydney, Australia.
Kidney international reports
|July 9, 2025
概括
甲基普雷迪尼索隆对IgA脏病 (IgAN) 患者有利,通过改善脏结果,无论基线蛋白尿或eGFR. 然而,对于患有晚期疾病和其他风险因素的患者,风险效益平衡可能不那么有利.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫抑制疗法 免疫抑制疗法
背景情况:
- 免疫球蛋白A脏病 (IgAN) 是脏疾病的常见原因之一.
- 较高的蛋白尿和较低的估计膜过率 (eGFR) 在IgAN中预测功能衰竭.
- 这些标记物对Igan中的皮质类固醇治疗反应的影响尚不清楚.
研究的目的:
- 评估甲基普雷迪尼索隆对脏的影响和Igan患者的安全结果.
- 为了确定基线蛋白尿和eGFR是否会在IGAN中改变对甲基prednisolone治疗的反应.
主要方法:
- 对TESTING试验的后期分析,涉及503名Igan参与者,蛋白尿≥1g/d.
- 参与者被随机分配到口服甲基普雷迪尼索隆 (全剂量或减少剂量) 或安慰剂.
- 根据基线蛋白尿 (1-<1.5,1.5-<3,≥3 g/d) 和eGFR (20-120 ml/min/1.73 m2) 的分层.
主要成果:
- 甲基普雷尼索隆可将主要结局 (eGFR下降,功能衰竭或死亡) 的风险降低47%,不论是基线蛋白尿或eGFR.
- 在所有子组中,在eGFR斜率和蛋白尿减少方面观察到一致的好处.
- 严重不良事件 (SAE) 与甲基prednisolone更高;绝对的SAE风险可能超过EGFR<30毫升/分钟/1.73米2的患者的好处.
结论:
- 甲基普雷尼索隆可以改善高风险Igan患者的结局,而不依赖蛋白尿或eGFR水平.
- 甲基普雷迪尼索隆的风险益处概况可能在患有晚期IGAN和毒性额外风险因素的患者中不太有利.
- 在IgAN治疗中启动皮质类固醇治疗时,需要仔细考虑个体患者的因素.
相关概念视频
01:26Nephrotic Syndrome II : Assessment and Medical Management
24
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
24
01:24Nephrotic Syndrome III : Nursing Management
48
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
48
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
59
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
59
01:17Factors Affecting Renal Clearance: Renal Impairment
165
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
165
01:28Chronic Kidney Disease III: Interprofessional Care
82
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
82
01:29Acute Kidney Injury III: Clinical Manifestations
97
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
97